1. Home
  2. TIPT vs AVXL Comparison

TIPT vs AVXL Comparison

Compare TIPT & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIPT
  • AVXL
  • Stock Information
  • Founded
  • TIPT 2007
  • AVXL 2004
  • Country
  • TIPT United States
  • AVXL United States
  • Employees
  • TIPT N/A
  • AVXL N/A
  • Industry
  • TIPT Property-Casualty Insurers
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TIPT Finance
  • AVXL Health Care
  • Exchange
  • TIPT Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • TIPT 808.7M
  • AVXL 761.3M
  • IPO Year
  • TIPT 2007
  • AVXL N/A
  • Fundamental
  • Price
  • TIPT $21.36
  • AVXL $8.25
  • Analyst Decision
  • TIPT
  • AVXL Strong Buy
  • Analyst Count
  • TIPT 0
  • AVXL 2
  • Target Price
  • TIPT N/A
  • AVXL $44.00
  • AVG Volume (30 Days)
  • TIPT 129.2K
  • AVXL 657.5K
  • Earning Date
  • TIPT 04-30-2025
  • AVXL 05-13-2025
  • Dividend Yield
  • TIPT 1.12%
  • AVXL N/A
  • EPS Growth
  • TIPT 107.58
  • AVXL N/A
  • EPS
  • TIPT 1.20
  • AVXL N/A
  • Revenue
  • TIPT $2,042,059,000.00
  • AVXL N/A
  • Revenue This Year
  • TIPT N/A
  • AVXL N/A
  • Revenue Next Year
  • TIPT N/A
  • AVXL N/A
  • P/E Ratio
  • TIPT $17.81
  • AVXL N/A
  • Revenue Growth
  • TIPT 15.66
  • AVXL N/A
  • 52 Week Low
  • TIPT $15.60
  • AVXL $3.51
  • 52 Week High
  • TIPT $26.90
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • TIPT 44.82
  • AVXL 40.05
  • Support Level
  • TIPT $21.03
  • AVXL $8.20
  • Resistance Level
  • TIPT $21.79
  • AVXL $8.81
  • Average True Range (ATR)
  • TIPT 0.67
  • AVXL 0.41
  • MACD
  • TIPT -0.06
  • AVXL -0.12
  • Stochastic Oscillator
  • TIPT 40.63
  • AVXL 3.13

About TIPT Tiptree Inc.

Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Share on Social Networks: